ArticleJournal of analytical atomic spectrometry2025
Ozone-mediated breakdown of microplastics in aqueous environments.
Article in Journal of analytical atomic spectrometry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Direct Characterization of Halogen-Based Microplastics via Single-Event ICP-Mass Spectrometry in Negative-Ion Mode.Analytical chemistry · 2026Article
- Design and optimization of an HVAC-integrated ozone disinfection system for the purified buffer room of PIVAS.iScience · 2026Article
- Beyond Removal: A Critical Review of Microplastic Mass Flux, In-Plant Transformation, and Elimination in WWTPs.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced oxidation processes (AOPs) are increasingly adopted in wastewater treatment to degrade persistent pollutants, including emerging targets such as microplastics (MPs). These particles enter aquatic systems through the fragmentation of bulk plastics and, as their size decreases, exhibit enhanced mobility, surface reactivity, and biological uptake potential. However, the efficiency of AOPs in removing MPs and their nanoscale derivatives (nanoplastics, NPs) remains poorly understood, partly due to the lack of suitable analytical tools. Small MPs and NPs often occur at trace levels and are obscured by colloidal and dissolved background in complex matrices. Moreover, growing evidence suggests that AOPs may promote fragmentation rather than complete degradation. Thus, the focus of this study is to investigate ozone as a reactive agent for MP degradation, using single-particle inductively coupled plasma - mass spectrometry (SP ICP-MS). The formation of nanoscale plastics was qualitatively assessed using dynamic light scattering (DLS). The degradation behaviour of primary MPs such as polystyrene (PS) and polytetrafluoroethylene (PTFE), and secondary MPs generated from bulk poly(methyl methacrylate) (PMMA) and polyvinyl chloride (PVC) was assessed. Ozone exposure led to progressive mass reduction for PS and PMMA, while PTFE and PVC showed greater oxidation resistance. SP ICP-MS revealed detailed transformations in mass, which were projected into size distributions, while DLS confirmed the formation of nanoscale particles in all cases. These findings highlight that ozone-based AOPs can promote nanoplastic formation, underscoring the need to evaluate treatment efficiency not only by particle removal but also with regard to the nature and behaviour of transformation products. The combined use of SP ICP-MS and DLS offers unique insights into MP degradation and the unintended formation of NPs during oxidative treatment, an aspect of particular relevance as AOPs are increasingly integrated into wastewater treatment under the revised European Urban Wastewater Treatment Directive (2024/3019).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.